top TOP
NEWS
August 23, 2022

Conquer Cancer and Israel Cancer Research Fund announce co-funding of 2022 Career Development Award

ICRF News | ICRF Press Release

Conquer Cancer, the ASCO Foundation, is pleased to announce Orit Kaidar-Person, MD, of Sheba Medical Center as the recipient of the 2022 Conquer Cancer – Israel Cancer Research Fund Career Development Award (CDA). 

Dr. Kaidar-Person’s proposed study entitled “BRILLIANT study: BReast mri-based artificial InteLLIgence to identify high risk areas in residual breast tissue after mAstectomy and recoNsTruction” aims to develop imaging-based (Breast MRI) artificial intelligence models, using the largest database in Israel from the Meirav Center at Sheba Tel Hashomer. This model will assist to the identification of areas at high risk for cancer recurrence after mastectomy and implant-based reconstruction.  

“This MRI-based model will highlight, on the patient’s breast images, the areas within the reconstructed breast that are at risk for cancer recurrence. This will help guide the selection and the extent of further treatment such as surgery or radiotherapy to decrease the risks for cancer recurrence. Our new technology should, hopefully, improve outcomes of thousands of breast cancer mastectomy patients worldwide by better identification of recurrence risks and improved options for subsequent treatments,” said Dr. Kaidar-Person.  

“ICRF is thrilled  to enhance its grants program by collaborating with Conquer Cancer once again.  Our joint effort enables us to expand our funding opportunities to the brightest and most promising cancer investigators in Israel.”

Beryl Chernov
ICRF National Executive Director

This is the third year of collaboration between Conquer Cancer and Israel Cancer Research Fund to award a CDA supporting high-quality clinical oncology research by an early-career physician scientist in Israel. The CDA is a three-year, $200,000 grant that provides resources to clinical and translational investigators during their initial years of faculty appointment when funding is especially challenging. The grant period starts on September 1, 2022. 

“ICRF is thrilled  to enhance its grants program by collaborating with Conquer Cancer once again.  Our joint effort enables us to expand our funding opportunities to the brightest and most promising cancer investigators in Israel,” noted Beryl Chernov, ICRF National Executive Director.

View Grant Recipient profile

Help End the Suffering Caused By Cancer

The answer to cancer is research. Support groundbreaking cancer research in Israel today: